News & Perspective

Jul 05, 2006

Jul 05, 2006

HHS has enough H5N1 vaccine for 4 million people

(CIDRAP News) – In an update on pandemic influenza preparedness efforts, the federal government said last week it had stockpiled enough vaccine against H5N1 avian influenza virus to inoculate about 4 million people and enough antiviral medication to treat about 6.3 million.

Jul 18, 2006

Jul 18, 2006

Novartis to build US cell-based flu vaccine plant

(CIDRAP News) – Novartis, the Swiss-based drug manufacturer, today announced plans to build what it says will be the first US plant to make cell-culture-based influenza vaccines.

The facility will be built in Holly Springs, N.C., at a total cost of about $600 million, the company said in a news release. It will be able to produce about 50 million doses of seasonal trivalent (three-strain) flu vaccine annually.

Aug 08, 2006

Aug 08, 2006

Professional groups call on White House to elevate role of pandemic flu vaccines

(CIDRAP News) – Two national groups of infectious disease experts urged the White House to make the development of vaccines the most important element in the nation's pandemic influenza plan.

Oct 02, 2006

Oct 02, 2006

FDA issues guide to ease production of cell-based vaccines

(CIDRAP News) – In a major push to modernize and speed the production of vaccines for pandemic influenza and other emerging threats, the US Food and Drug Administration (FDA) last week issued new guidance on how to safely and effectively develop new cell-based vaccines.

May 25, 2007

May 25, 2007

Congress cut pandemic funds before passing spending bill

(CIDRAP News) – Farmers, airlines, and salmon fishermen stood to benefit when Congress passed a modestly trimmed emergency spending bill yesterday, but pandemic influenza preparedness lost out.

Oct 24, 2007

Oct 24, 2007

Pandemic vaccine proposal favors health workers, children

(CIDRAP News) – A federal interagency working group yesterday released a draft report detailing how the government would allocate limited vaccine supplies if a severe influenza pandemic grips the United States, offering a tiered approach that flags key health and public safety personnel and children as top priorities.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE A seven-part series on the chances for immunizing the world against pandemic flu

Editor's note: This article was originally published in CIDRAP News as a seven-part series running from October 25 through November 2, 2007. It investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Jan 23, 2008

Jan 23, 2008

GAO cites barriers to antiviral, vaccine roles in pandemic

(CIDRAP News) – Antiviral medications and vaccines are two tools that many government and health officials hope will stall the spread of an influenza pandemic, but each strategy has daunting challenges, according to a new report from Congress's Government Accountability Office (GAO).

Oct 03, 2008

Oct 03, 2008

Plant cancellation shows problems in flu vaccine business

(CIDRAP News) – A flu vaccine manufacturer's decision not to build a US facility has highlighted the perpetual mismatch between flu-shot supply and demand—and the reality that the mismatch may undermine plans for pandemic flu vaccines.

Oct 24, 2008

Oct 24, 2008

WHO's draft pandemic flu guidance revises phases

(CIDRAP News) – The World Health Organization (WHO) has drafted a revised pandemic influenza preparedness plan that updates the definitions of pandemic phases and puts more emphasis on the social and economic effects of a global epidemic, among other changes.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»